Health

First ‘gene silencing’ drug for Alzheimer’s disease shows promise

In a groundbreaking trial conducted at University College London (UCL) and University College London Hospitals (UCLH), a new genetic therapy for Alzheimer’s disease has been discovered, which effectively lowers the levels of the harmful tau protein, a known contributor to the disease. The trial, led by consultant neurologist Dr. Catherine Mummery, is the first to […]

DAILY LINKS TO YOUR INBOX

PROMPT ENGINEERING

Prompt Engineering Guides

ShareGPT

 

©2024 The Horizon